231 related articles for article (PubMed ID: 29636136)
21. Cell uptake enhancement of folate targeted polymer coated magnetic nanoparticles.
Licciardi M; Scialabba C; Cavallaro G; Sangregorio C; Fantechi E; Giammona G
J Biomed Nanotechnol; 2013 Jun; 9(6):949-64. PubMed ID: 23858959
[TBL] [Abstract][Full Text] [Related]
22. Idarubicin-loaded folic acid conjugated magnetic nanoparticles as a targetable drug delivery system for breast cancer.
Gunduz U; Keskin T; Tansık G; Mutlu P; Yalcin S; Unsoy G; Yakar A; Khodadust R; Gunduz G
Biomed Pharmacother; 2014 Jul; 68(6):729-36. PubMed ID: 25194441
[TBL] [Abstract][Full Text] [Related]
23. Nanosoldiers: A promising strategy to combat triple negative breast cancer.
Pawar A; Prabhu P
Biomed Pharmacother; 2019 Feb; 110():319-341. PubMed ID: 30529766
[TBL] [Abstract][Full Text] [Related]
24. In vitro cell uptake of biocompatible magnetite/chitosan nanoparticles with high magnetization: a single-step synthesis approach for in-situ-modified magnetite by amino groups of chitosan.
Wang Y; Li B; Xu F; Jia D; Feng Y; Zhou Y
J Biomater Sci Polym Ed; 2012; 23(7):843-60. PubMed ID: 21418750
[TBL] [Abstract][Full Text] [Related]
25. Design of multifunctional magnetic iron oxide nanoparticles/mitoxantrone-loaded liposomes for both magnetic resonance imaging and targeted cancer therapy.
He Y; Zhang L; Zhu D; Song C
Int J Nanomedicine; 2014; 9():4055-66. PubMed ID: 25187709
[TBL] [Abstract][Full Text] [Related]
26. Effects of iron oxide nanoparticles on biological responses and MR imaging properties in human mammary healthy and breast cancer epithelial cells.
Zhang Q; Rajan SS; Tyner KM; Casey BJ; Dugard CK; Jones Y; Paredes AM; Clingman CS; Howard PC; Goering PL
J Biomed Mater Res B Appl Biomater; 2016 Jul; 104(5):1032-42. PubMed ID: 26013845
[TBL] [Abstract][Full Text] [Related]
27. RGDS-functionalized polyethylene glycol hydrogel-coated magnetic iron oxide nanoparticles enhance specific intracellular uptake by HeLa cells.
Nazli C; Ergenc TI; Yar Y; Acar HY; Kizilel S
Int J Nanomedicine; 2012; 7():1903-20. PubMed ID: 22619531
[TBL] [Abstract][Full Text] [Related]
28. Triple negative breast cancer therapy with CDK1 siRNA delivered by cationic lipid assisted PEG-PLA nanoparticles.
Liu Y; Zhu YH; Mao CQ; Dou S; Shen S; Tan ZB; Wang J
J Control Release; 2014 Oct; 192():114-21. PubMed ID: 25016158
[TBL] [Abstract][Full Text] [Related]
29. Lipid nanocarriers of a lipid-conjugated estrogenic derivative inhibit tumor growth and enhance cisplatin activity against triple-negative breast cancer: pharmacokinetic and efficacy evaluation.
Andey T; Sudhakar G; Marepally S; Patel A; Banerjee R; Singh M
Mol Pharm; 2015 Apr; 12(4):1105-20. PubMed ID: 25661724
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer.
Ndinguri M; Middleton L; Unrine J; Lui S; Rollins J; Nienaber E; Spease C; Williams A; Cormier L
PLoS One; 2023; 18(10):e0287151. PubMed ID: 37816015
[TBL] [Abstract][Full Text] [Related]
31. Search for novel therapies for triple negative breast cancers (TNBC): analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GHRH).
Buchholz S; Seitz S; Engel JB; Montero A; Ortmann O; Perez R; Block NL; Schally AV
Horm Mol Biol Clin Investig; 2012 Apr; 9(1):87-94. PubMed ID: 25961354
[TBL] [Abstract][Full Text] [Related]
32. Targeted delivery of doxorubicin to breast cancer cells by magnetic LHRH chitosan bioconjugated nanoparticles.
Varshosaz J; Hassanzadeh F; Aliabadi HS; Khoraskani FR; Mirian M; Behdadfar B
Int J Biol Macromol; 2016 Dec; 93(Pt A):1192-1205. PubMed ID: 27693338
[TBL] [Abstract][Full Text] [Related]
33. LHRH receptor-mediated delivery of siRNA using polyelectrolyte complex micelles self-assembled from siRNA-PEG-LHRH conjugate and PEI.
Kim SH; Jeong JH; Lee SH; Kim SW; Park TG
Bioconjug Chem; 2008 Nov; 19(11):2156-62. PubMed ID: 18850733
[TBL] [Abstract][Full Text] [Related]
34. Targeted chemotherapy for triple-negative breast cancers via LHRH receptor.
Föst C; Duwe F; Hellriegel M; Schweyer S; Emons G; Gründker C
Oncol Rep; 2011 May; 25(5):1481-7. PubMed ID: 21331448
[TBL] [Abstract][Full Text] [Related]
35. Pegylated and amphiphilic Chitosan coated manganese ferrite nanoparticles for pH-sensitive delivery of methotrexate: Synthesis and characterization.
Karimi Z; Abbasi S; Shokrollahi H; Yousefi G; Fahham M; Karimi L; Firuzi O
Mater Sci Eng C Mater Biol Appl; 2017 Feb; 71():504-511. PubMed ID: 27987737
[TBL] [Abstract][Full Text] [Related]
36. Enhanced cell uptake of superparamagnetic iron oxide nanoparticles through direct chemisorption of FITC-Tat-PEG₆₀₀-b-poly(glycerol monoacrylate).
Wang C; Qiao L; Zhang Q; Yan H; Liu K
Int J Pharm; 2012 Jul; 430(1-2):372-80. PubMed ID: 22531849
[TBL] [Abstract][Full Text] [Related]
37. Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?
Corona SP; Roviello G; Strina C; Milani M; Allevi G; Aguggini S; Zanoni D; Generali D
Future Oncol; 2017 Nov; 13(27):2473-2477. PubMed ID: 29121807
[TBL] [Abstract][Full Text] [Related]
38. Development and Evaluation of Crocetin-Functionalized Pegylated Magnetite Nanoparticles for Hepatocellular Carcinoma.
Ibrahim S; Baig B; Hisaindee S; Darwish H; Abdel-Ghany A; El-Maghraby H; Amin A; Greish Y
Molecules; 2023 Mar; 28(7):. PubMed ID: 37049645
[TBL] [Abstract][Full Text] [Related]
39. Enhanced Cellular Uptake of Silica-Coated Magnetite Nanoparticles Compared with PEG-Coated Ones in Stem Cells.
Lee DH; Kang M; Lee HJ; Kim JA; Choi YK; Cho H; Park JK; Park TH; Jung H
J Nanosci Nanotechnol; 2015 Aug; 15(8):5512-9. PubMed ID: 26369110
[TBL] [Abstract][Full Text] [Related]
40. Preparation and in vitro evaluation of Methotrexate-loaded magnetic nanoparticles modified with biocompatible copolymers.
Jahangiri S; Akbarzadeh A
Artif Cells Nanomed Biotechnol; 2016 Nov; 44(7):1733-40. PubMed ID: 26479846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
